| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |